Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis
Yujie Wang, Qi Sun, Ying Ye, Xiaoting Sun, Sisi Xie, Yuhang Zhan, Jian Song, Xiaoqin Fan, Bin Zhang, Ming Yang, Lei Lv, Kayoko Hosaka, Yunlong Yang, Guohui Nie
Yujie Wang, Qi Sun, Ying Ye, Xiaoting Sun, Sisi Xie, Yuhang Zhan, Jian Song, Xiaoqin Fan, Bin Zhang, Ming Yang, Lei Lv, Kayoko Hosaka, Yunlong Yang, Guohui Nie
View: Text | PDF
Research Article Immunology Oncology

FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis

  • Text
  • PDF
Abstract

Molecular signaling in the tumor microenvironment (TME) is complex, and crosstalk among various cell compartments in supporting metastasis remains poorly understood. In particular, the role of vascular pericytes, a critical cellular component in the TME, in cancer invasion and metastasis warrants further investigation. Here, we report that an elevation of FGF-2 signaling in samples from patients with nasopharyngeal carcinoma (NPC) and xenograft mouse models promoted NPC metastasis. Mechanistically, tumor cell–derived FGF-2 strongly promoted pericyte proliferation and pericyte-specific expression of an orphan chemokine (C-X-C motif) ligand 14 (CXCL14) via FGFR1/AHR signaling. Gain- and loss-of-function experiments validated that pericyte-derived CXCL14 promoted macrophage recruitment and polarization toward an M2-like phenotype. Genetic knockdown of FGF2 or genetic depletion of tumoral pericytes blocked CXCL14 expression and tumor-associated macrophage (TAM) infiltration. Pharmacological inhibition of TAMs by clodronate liposome treatment resulted in a reduction of FGF-2–induced pulmonary metastasis. Together, these findings shed light on the inflammatory role of tumoral pericytes in promoting TAM-mediated metastasis. We provide mechanistic insight into an FGF-2/FGFR1/pericyte/CXCL14/TAM stromal communication axis in NPC and propose an effective antimetastasis therapy concept by targeting a pericyte-derived inflammation for NPC or FGF-2hi tumors.

Authors

Yujie Wang, Qi Sun, Ying Ye, Xiaoting Sun, Sisi Xie, Yuhang Zhan, Jian Song, Xiaoqin Fan, Bin Zhang, Ming Yang, Lei Lv, Kayoko Hosaka, Yunlong Yang, Guohui Nie

×

Figure 6

Genetic depletion of pericytes ablates CXCL14 and TAM infiltration in the TME.

Options: View larger image (or click on image) Download as PowerPoint
Genetic depletion of pericytes ablates CXCL14 and TAM infiltration in th...
(A) Growth rates of 4T1-vector and 4T1–FGF-2–overexpressing tumor cells in vitro. (B and C) Cell migration (n = 8 samples per group) and chemotactic ability (n = 6 samples per group) of 4T1-vector and 4T1–FGF-2–overexpressing tumor cells. (D) Tumor-bearing WT and NG2-TK mice were administrated with ganciclovir when the tumor reached 0.5 cm3. H&E staining and immunofluorescence localization of CD31 (red), NG2 (green), and DAPI (blue) signals in 4T1-vector and 4T1-FGF-2–overexpressing tumor–bearing WT and NG2-TK mice (n = 6 mice per group). Scale bar in upper panel: 50 μm. Scale bar in lower panel: 100 μm. Quantification of CD31+ signals, NG2+ signals, pericyte coverage, and average vessel diameters (n = 8 random fields per group). (E) qPCR quantification of Cxcl14 mRNA levels of 4T1-vector and 4T1–FGF-2–overexpressing tumor tissues from WT and NG2-TK mice (n = 6 mice per group). (F) F4/80 (brown) IHC in vector and FGF-2 tumor with or without NG2+ pericyte depletion and in CXCL14-administrated, NG2+ pericyte–depleted FGF-2 tumor (n = 6 mice per group). Scale bar: 50 μm. Quantification of F4/80+ signals (n = 8 random fields per group) (G) CD206 (brown) IHC in FGF-2 tumor with or without NG2+ pericyte depletion or CXCL14 administration (n = 6 mice per group). Scale bar: 50 μm. Quantification of CD206+ signals (n = 8 random fields per group) (H) qPCR quantification of Cd206 mRNA levels in F4/80+ TAMs from various tumor groups (n = 3 samples per group). *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired 2-tailed Student’s t test (A–D) or 1-way ANOVA with Tukey’s multiple-comparison analysis (E–H). Data are presented as mean ± SD.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts